Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 26, Issue 5, 2016, Pages 414-418

  Giacobbe, A ^a   Granese, R ^a   Grasso, R ^a   Salpietro, V ^b   Corrado, F ^a   Giorgianni, G ^b   Foti, G ^a   Amadore, D ^a   Triolo, O ^a   Giunta, L ^b   Di Benedetto, A ^b  

^a Microbiological and Biomedical Sciences ^*  (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Gestational diabetes mellitus; High mobility group box 1; Insulin resistance

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; AUTACOID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; HMGB1 PROTEIN, HUMAN; INSULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; THIRD TRIMESTER PREGNANCY; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DIABETES, GESTATIONAL; GLUCOSE TOLERANCE TEST; METABOLISM; PREDICTIVE VALUE; PREGNANCY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; YOUNG ADULT;

ADULT; AREA UNDER CURVE; BIOMARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HMGB1 PROTEIN; HUMANS; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84963613024     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2016.02.007     Document Type: Article

References (22)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care January 2013, 36(Suppl. 1):S67-S74.
2. Wendland E.M., Torloni M.R., Falavigna M., Trujillo J., Dode M.A., Campos M.A., et al. Gestational diabetes and pregnancy outcomes-a systematic review of the World Health Organization (WHO) and the International association of diabetes in pregnancy study groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth 2012 Mar 31, 12:23.
3. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., Coustan D.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002.
4. Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., Catalano P.A., Damm P., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
5. Gomes C.P., Torloni M.R., Gueuvoghlanian-Silva B.Y., Alexandre S.M., Mattar R., Daher S. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol 2013 Jun, 69(6):545-557.
6. López-Tinoco C., Roca M., Fernández-Deudero A., García-Valero A., Bugatto F., Aguilar-Diosdado M., et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus. Cytokine 2012 Apr, 58(1):14-19.
7. Vrachnis N., Antonakopoulos N., Iliodromiti Z., Dafopoulos K., Siristatidis C., Pappa K., et al. Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring. Exp Diabetes Res 2012, 2012:538474.
8. Lacroix M., Battista M.C., Doyon M., Ménard J., Ardilouze J.L., Perron P., et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 2013 Jun, 36(6):1577-1583.
9. Bao W., Baecker A., Song Y., Kiely M., Liu S., Zhang C. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. Metabolism 2015 Jun, 64(6):756-764.
10. Goodwin G.H., Brown E., Walker J.M., Johns E.W. The isolation of three new high mobility group nuclear proteins. Biochim Biophys Acta 1980 Jun 26, 623:329-338.
11. Arrigo T., Chirico V., Salpietro V., Munafò C., Ferraù V., Gitto E., et al. HMGB1: a new biomarker of metabolic syndrome in obese children. Eur J Endocrinol 2013 Mar 15, 168(4):631-638.
12. Naruse K., Sado T., Noguchi T., Tsunemi T., Yoshida S., Akasaka J., et al. Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response. J Reprod Immunol 2012 Mar, 93(2):69-74.
13. Nagamori T., Koyano S., Asai Y., Nohara F., Okamoto T., Nagaya K., et al. Sequential changes in pathophysiology of systemic inflammatory response in a disseminated neonatal herpes simplex virus (HSV) infection. J Clin Virol 2012 Mar, 53(3):265-267.
14. Daher S., Torloni M.R., Gueuvoghlanian-Silva B.Y., Moron A.F., Mattar R. Inflammatory mediator gene polymorphisms and gestational diabetes: a review of the literature. J Reprod Immunol 2011, 90:111-116.
15. Oh Y.J., Youn J.H., Ji Y., Lee S.E., Lim K.J., Choi J.E., et al. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol 2009 May 1, 182(9):5800-5809.
16. Wang B., Koga K., Osuga Y., Hirata T., Saito A., Yoshino O., et al. High mobility group box 1 (HMGB1) levels in the placenta and in serum in Preeclampasia. Am J Reprod Immunol 2011, 66:143-148.
17. Atègbo J.M., Grissa O., Yessoufou A., Hichami A., Dramane K.L., Moutairou K., et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006, 91(10):4137-4143.
18. Meller M., Qiu C., Vadachkoria S., Abetew D.F., Luthy D.A., Williams M.A. Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus. Physiol Res 2006, 55(5):501-512.
19. Yessoufou A., Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory. Exp Diabetes Res 2011, 2011:218598.
20. Hagiwara S., Iwasaka H., Hasegawa A., Koga H., Noguchi T. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med 2008 Aug, 36(8):2407-2413.
21. Nogueira-Machado J.A., Volpe C.M., Veloso C.A., Chaves M.M. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets 2011 Aug, 15(8):1023-1035.
22. Guzmán-Ruiz R., Ortega F., Rodríguez A., Vázquez-Martínez R., Díaz-Ruiz A., Garcia-Navarro S., et al. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells. Int J Obes (Lond) 2014 Dec, 38(12):1545-1554.